| Execution period | 10 days |
|---|
NSE filing, NSE: GKSL. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Kidney and Super Speciality Ltd: key numbers
- Share price
- ₹163.59
- Market cap
- ₹1,290 Cr
- Revenue (annual)
- ₹82.01 Cr
- Net profit (annual)
- ₹15.50 Cr
- P/E (TTM)
- 81.5×Sector 53.7×
- Promoter holding
- 71.45%+0.00% QoQ
- FII holding
- 6.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Kidney and Super Speciality Ltd
All →Gujarat Kidney and Super Speciality Board Meeting Date
Gujarat Kidney will hold a board meeting on 04 Nov 2026 to consider unaudited quarterly results. The trading window closes from 01 Oct 2026.
Gujarat Kidney and Super Speciality Other Announcement
This is a routine quarterly shareholding pattern disclosure for the period ended September 30, 2026, filed under SEBI Regulation 31.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited held its 7th Annual General Meeting on September 28, 2026. Shareholders approved financial statements, director appointments, and various regulatory borrowing and investment limits.
Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney and Super Speciality Limited issued a corrigendum to its FY 2025-26 Annual Report. The update includes missing Secretarial Audit observations and management responses.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited has issued a notice for its 7th Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statements, director appointments, and related party transactions.
- Value
- ₹1.78 Cr
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited filed a revised Annual Report for FY 2025-26. The document also includes the notice for its 7th Annual General Meeting.
Other capacity expansion announcements
All →Gujarat Inject (Kerala) Capacity Expansion
Gujarat Inject Kerala Ltd leased two Ahmedabad industrial premises for factory and R&D use. The five-year deals include 5% escalation and a two-year lock-in.
- Execution
- 5 years (2-year lessee lock-in)
Aelea Commodities Capacity Expansion: ₹114 Cr Investment
Aelea's board approved ₹114 crore to add 90 MT manufacturing capacity and build a staff housing colony in Surat. Completion expected within 30 months from February 2027.
- Value
- ₹114.0 Cr
- Execution
- 30 months from February 2027
- manufacturing capacity addition
- 90.0 MT
Kaynes Technology India Capacity Expansion
Kaynes Technology has incorporated a wholly owned subsidiary, Kaynes Arabia Electronics Company, in Saudi Arabia to manufacture electronic products for GCC markets. The company holds 100% ownership and the authorised share capital is SAR 100,000.
Vaibhav Vyapaar Capacity Expansion
Vaibhav Vyapaar opened a new business office in Bangalore, commencing operations on 02 November 2026. The approximately 5,500 sq ft office supports operational expansion.
- office area
- 5500.0 sq ft
Borana Weaves Capacity Expansion: ₹49.92 Cr Investment
Borana Weaves plans 384 new looms, adding 110.60 million metres of yearly capacity. The Rs 49.92 Crore investment will be phased through March 2027.
- Value
- ₹49.92 Cr
- Execution
- Phase 1 by December 2026; Phase 2 by March 2027
- annual greige fabric production capacity
- 110.6 million metres per year
Sita Enterprises Capacity Expansion
Sita Enterprises' board approved changing its main object to investment, lending and financial services. Name change and new MOA/AOA also await shareholder approval via postal ballot.